| Literature DB >> 28911652 |
Khaled Elbanna1,2, Osama Mohamed Sarhan2,3, Manal Khider4, Mohamed Elmogy5, Hussein Hasan Abulreesh2, Mohamed Rabie Shaaban2,6.
Abstract
In this study, 120 lactic acid bacterial strains from different fermented dairy products as well as 10 bacterial intestinal isolates were evaluated for in vitro and in vivo degradation of various food azo dyes. Of these isolates, lactic acid bacteria (LAB) strains 13 and 100 and the intestinal isolates Ent2 and Eco5 exhibited 96-98% degradation of the tested food azo dyes within 5-6 hours. High performance liquid chromatography mass spectra of sunset yellow (E110) and carmoisine (E122) anaerobic degradation products by the intestinal isolates showed that they were structurally related to toxic aromatic amines. For an in vivo study, eight groups of rats were treated for 90 days with either the food azo dyes or their degradation products. All groups were kept for a further 30 days as recovery period and then dissected at 120 days. Hematological, histopathological, and protein markers were assessed. Rats treated with either E110/E122 or their degradation products exhibited highly significant changes in red blood cell count, hemoglobin, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, and white blood cell count. In addition, alanine and aspartate aminotransferases, amylase, total bilirubin, blood urea nitrogen, creatinine, glucose, total protein, and globulins were significantly increased. Furthermore, marked histopathological alterations in the liver, kidney, spleen, and small intestine were observed. Significant decreases in inflammation and a noticeable improvement in the liver, kidney, spleen, and small intestine of rats treated with LAB and food azo dyes simultaneously were observed. Finally, these results provide a reliable basis for not only a better understanding of the histological and biochemical effects of food additives, but also for early diagnostics. In addition, LAB strains 13 and 100 may play an important role as potential probiotics in food and dairy technology as a probiotic lactic acid starter.Entities:
Keywords: dairy products; food additives; food azo dyes; lactic acid bacteria; probiotic bacteria
Mesh:
Substances:
Year: 2017 PMID: 28911652 PMCID: PMC9328831 DOI: 10.1016/j.jfda.2017.01.005
Source DB: PubMed Journal: J Food Drug Anal Impact factor: 6.157
Screening for food azo dye degrading bacteria.
| Bacterial isolates | Decolorization percentage (%) of different food azo dyes under anaerobic condition | ||||
|---|---|---|---|---|---|
|
| |||||
| E102 (D1) | E110 (D5) | E122 (D7) | E124 (D2) | ||
| LAB2 | 88.20 | 94.70 | 94.00 | 88.90 | |
| LAB11 | 89.50 | 95.50 | 93.0 | 86.60 | |
| LAB13 | 92.00 | 95.70 | 96.20 | 92.40 | |
| LAB100 | 90.40 | 94.20 | 94.70 | 90.90 | |
| LAB107 | 87.60 | 91.10 | 95.00 | 88.50 | |
| Mean | 89.54 | 94.24 | 94.58 | 89.46 | |
| Eco1 | 68.20 | 70.80 | 73.40 | 64.40 | |
| Eco2 | 69.70 | 72.40 | 75.00 | 61.50 | |
| Eco3 | 67.10 | 72.10 | 74.90 | 64.40 | |
| Eco4 | 69.80 | 70.50 | 73.70 | 65.80 | |
| Eco5 | 70.00 | 74.20 | 77.90 | 69.70 | |
| Mean | 68.96 | 72.00 | 74.98 | 65.16 | |
| Ent1 | 57.00 | 62.70 | 66.80 | 54.60 | |
| Ent2 | 58.50 | 68.90 | 67.20 | 60.50 | |
| Ent3 | 59.30 | 62.20 | 65.60 | 55.70 | |
| Ent4 | 56.80 | 64.80 | 64.70 | 57.20 | |
| Ent5 | 57.40 | 61.50 | 65.90 | 55.40 | |
| Mean | 57.80 | 64.02 | 66.04 | 56.68 | |
| Intestinal consortium | 96.80 | 98.60 | 97.70 | 96.20 | |
Lactic acid bacterial strains (LAB 11), (LAB 2 and LAB 13), (LAB 100), and (LAB 107) were characterized as Lactobacillus rhamnosus (Accession No. HQ177094), Lactobacillus casei (Accession No. HQ177095), Lactobacillus paracasei (Accession No. HQ177096), respectively.
Note. From: “Safe biodegradation of textile azo dyes by newly isolated lactic acid bacteria and detection of plasmids associated with degradation,” by K. Elbanna, G. Hassan, M. Khider, R. Mandour, 2010, J Bioremed Biodegrad, 1, p. 110. Copyright year 2010, Journal of International Biodegradation and Bioremediation (ISSN: 2155-6199) is published by OMICS (https://www.omicsonline.org/bioremediation-biodegradation.php). With permission.
Bacterial consortium consists of isolates Eco5 and Ent2.
Figure 1Degradation (%) of food azo dyes (A) E110 and (B) E122 at different concentrations by a mixture of lactic acid bacterial isolates LAB13 and LAB100 and by the intestinal consortium. Decolorization (%) at different intervals (min) of (C) E110 and (D) E122 by a mixture of LAB13 and LAB100 and by the intestinal consortium. LAB = lactic acid bacteria.
Figure 2Mass spectra of (A) E110 dye prior to degradation, (B, C) degradation products of E110 dye by the intestinal bacterial consortium, (D) E122 dye prior to degradation, (E, F) degradation products of E122 dye.
Effect of food azo dyes and their degradation products on body weight.
| Groups ( | Rat groups ( | |||||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| G1 | G2 | G3 | G4 | G5 | G6 | G7 | G8 | |
| Gained body weight | 148.52 ± 8.66e | 153.55 ± 7.47bc | 155.76 ± 7.92a | 151.71 ± 8.25d | 154.18 ± 6.97ab | 154.53 ± 8.56ab | 152.21 ± 7.67cd | 150.19 ± 7.74d |
| Body weight (%) | — | 3.38% | 4.87% | 2.14% | 3.81% | 4.04% | 2.48% | 1.12% |
Mean values ± standard error. Means of treatments having the same letter(s) within a column are not significantly different (p < 0.05).
Effect of food azo dyes and their degradation products on complete blood count.
| Treatments | RBC (1012/L) | HGB (g/dL) | HCT (%) | MCV (fL) | MCH (pg) | MCHC (g/dL) | PLT (109/L) | WBC (109/L) |
|---|---|---|---|---|---|---|---|---|
| G1 | 7.04 ± 0.14cd | 13.95 ± 0.38bc | 39.79 ± 0.28abcd | 56.50 ± 0.87a | 19.85 ± 0.95ab | 35.00 ± 1.21bcd | 772.67 ± 99 | 2.27 ± 0.35d |
| G2 | 7.94 ± 0.37abc | 13.85 ± 0.44bc | 42.53 ± 1.01abc | 54.00 ± 1.29abc | 17.50 ± 0.4cd | 32.60 ± 0.53cd | 612.50 ± 153 | 6.89 ± 1.26a |
| G3 | 7.17 ± 0.44bcd | 13.87 ± 0.48bc | 38.97 ± 2.91bcd | 54.33 ± 1.76abc | 19.40 ± 0.62abc | 35.87 ± 2.05bc | 718.50 ± 39 | 4.23 ± 1.13bcd |
| G4 | 8.45 ± 0.17a | 14.45 ± 0.32ab | 44.12 ± 0.16a | 53.00 ± 0.58bc | 21.35 ± 1.18a | 40.45 ± 2.86a | 865.50 ± 158 | 5.19 ± 0.46abc |
| G5 | 8.35 ± 0.47a | 15.05 ± 0.32a | 42.92 ± 1.37ab | 55.00 ± 1.15ab | 19.65 ± 0.72ab | 35.55 ± 0.49bcd | 707.50 ± 15 | 6.61 ± 1.32bc |
| G6 | 8.07 ± 0.04ab | 15.05 ± 0.03a | 41.38 ± 0.05abc | 54.90 ± 0.06ab | 18.40 ± 0.06bcd | 36.25 ± 0.09bc | 715.85 ± 0.09 | 6.60 ± 0.06ab |
| G7 | 8.37 ± 0.40a | 15.00 ± 0.33ab | 42.51 ± 1.24abc | 54.10 ± 1.10ab | 18.35 ± 0.15bcd | 35.51 ± 0.40bcd | 615.50 ± 150 | 6.92 ± 1.30a |
| G8 | 7.23 ± 0.13bcd | 14.10 ± 0.06abc | 38.24 ± 0.38bcd | 55.00 ± 0.58ab | 19.95 ± 0.14ab | 36.95 ± 0.03b | 713.50 ± 1.44 | 3.94 ± 0.03cd |
| ANOVA Sig | 0.005 | 0.009 | 0.021 | 0.013 | 0.001 | 0.001 | 0.445 | 0.000 |
Mean values ± standard error. Means of treatments having the same letter(s) within a column are not significantly different (p < 0.05).
ANOVA = analysis of variance; HCT = hematocrit; HGB = hemoglobin; MCH = mean corpuscular hemoglobin; MCHC = mean corpuscular hemoglobin concentration; PLT = blood platelets; RBC = red blood cells; WBC = white blood cells.
Figure 3Histological changes in rat liver induced by E110, E122, and their in vitro or in vivo degradation products. Abbreviations (liver): AK = atrophied Kupffer cell(s); Ap = apoptotic nuclei; At = atrophied hepatocytes; BD = bile duct; BH = binucleated hepatocytes; Ca = canaliculus; CR = central region of the hepatic lobule; CV = central vein; DB = dilated bile duct; DC = destructed hepatic cords; DD = dilated Disse space; DH = degenerated hepatocytes; DK = degenerated Kupffer cells; FC = fatty changes; FD = fatty degeneration; H = hepatocytes; HC = hepatic cords; HK = hpertrophied Kupffer cells; IC = inflammatory cells infiltrations; Ka = karyomegaly; KC = Kupffer cells; KP = Kupffer cell proliferation; MR = medial region of the hepatic lobule; ND = normal Disse space; Oe = oedema; PA = portal area; PN = pyknotic nucleus; PR = peripheral region of the hepatic lobule; PV = portal vein; RD = remnants of degenerated hepatocytes; S = sinusoid(s); SD = sever degeneration in the hepatocytes; V = cytoplasmic vacuolations; VN = vacuolated nuclei.
Figure 4Histological changes in rat kidney induced by E110, E122, and their in vitro or in vivo degradation products. AG = atrophied glomerulus; BS = Bowman’s space; BV = dilated blood vessel; CB = congested blood vessel; CG = congested glomerular tufts; DE = degenerated epithelia of renal tubules; DG = degeneration in the glomerular tufts; DT = Degenerated tubules; DU = dilated urinary space; Gl = glomerulus; GT = glomerular tuft(s); Hc = hypercellularity; He = hemorrhage; Hy = hyalinosis; IC = inflammatory cells infiltrations; IF = interstitial fibrosis; Oe = oedema; PE = parietal epithelium; PF = polyps formation; PH = periglomerular hyalinosis; RA = renal arteriole; RS = renal space; RT = renal tubules; US = urinary space of Bowman’s capsule; VE = cytoplasmic vacuolization in the epithelium of renal tubules.
Figure 5Histological changes in rat spleen induced by E110 and E122 and their in vitro or in vivo degradation products. Abbreviations (spleen): AG = atrophied glomerulus; BS = Bowman’s space; BV = dilated blood vessel; CB = congested blood vessel; CG = congested glomerular tufts; DE = degenerated epithelia of renal tubules; DG = degeneration in the glomerular tufts; DT = degenerated tubules; DU = dilated urinary space; Gl = glomerulus; GT = glomerular tuft(s); Hc = hypercellularity; He = hemorrhage; Hy = hyalinosis; IC = inflammatory cells infiltrations; IF = interstitial fibrosis; Oe = oedema; PE = parietal epithelium; PF = polyps formation; PH = periglomerular hyalinosis; RA = renal arteriole; RS = renal space; RT = renal tubules; US = urinary space of Bowman’s capsule; VE = cytoplasmic vacuolization in the epithelium of renal tubules. Abbreviations (stomach): ML = muscle layer; MU = mucosal layer; SL = submucosal layer.
Effect of food azo dyes and their degradation products on liver function.
| Group | ALB (G/dL) | ALP (U/L) | ALT (U/L) | AST (U/L) | AMY (U/L) | TBIL (mg/dL) |
|---|---|---|---|---|---|---|
| G1 | 4.57 ± 0.10a | 5.05 ± 0.03a | 60.50 ± 0.29a | 132.33 ± 0.29f | 500.50 ± 0.29d | 0.21 ± 0.01c |
| G2 | 4.05 ± 0.03b | 5.00 ± 0.05ab | 122.00 ± 0.58f | 269.62 ± 0.58e | 618.00 ± 0.58cd | 0.31 ± 0.00ab |
| G3 | 4.10 ± 0.10b | 4.95 ± 0.03abc | 128.45 ± 0.32g | 285.88 ± 0.32d | 798.50 ± 0.29b | 0.32 ± 0.01a |
| G4 | 3.75 ± 0.05c | 5.00 ± 0.00ab | 156.50 ± 0.29d | 355.89 ± 0.29b | 737.50 ± 0.29b | 0.31 ± 0.01ab |
| G5 | 3.35 ± 0.05d | 4.95 ± 0.03abc | 185.50 ± 0.29b | 410.35 ± 0.29a | 684.50 ± 0.29c | 0.32 ± 0.00a |
| G6 | 4.05 ± 0.05b | 5.00 ± 0.00ab | 142.50 ± 0.29e | 315.93 ± 0.29c | 703.50 ± 0.29bc | 0.31 ± 0.00ab |
| G7 | 3.85 ± 0.05c | 4.85 ± 0.09bc | 158.50 ± 0.29c | 351.49 ± 0.29b | 937.50 ± 0.29a | 0.31 ± 0.00ab |
| G8 | 4.61 ± 0.04a | 5.15 ± 0.07a | 57.97 ± 0.34a | 128.13 ± 0.51f | 590.50 ± 0.29c | 0.25 ± 0.01c |
| ANOVA Sig. | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mean values ± standard error. Means of treatments having the same letter(s) within a column are not significantly different (p < 0.05).
ALB = albumin; ALP = alkaline phosphatase; ALT = alanine aminotransferase; AMY = amylase; ANOVA = analysis of variance; BUN = blood urea nitrogen; CRE = creatinine; Glob = globulins; TBIL = total bilirubin; TP = total phosphorus.
Effect of food azo dyes and their degradation products on kidney function.
| Treatments | CRE (mg/dL) | GLU (mg/dL) | TP (g/dL) | Glob (g/dL) | BUN (mg/dL) |
|---|---|---|---|---|---|
| G1 | 0.21 ± 0.01b | 82.52 ± 0.25c | 6.85 ± 0.03d | 2.70 ± 0.00c | 12.90 ± 0.58ef |
| G2 | 0.32 ± 0.01a | 100.50 ± 0.29b | 6.90 ± 0.06c | 3.65 ± 0.03b | 16.05 ± 0.03b |
| G3 | 0.32 ± 0.01a | 108.50 ± 0.29a | 6.80 ± 0.06d | 3.70 ± 0.06b | 17.90 ± 0.58a |
| G4 | 0.31 ± 0.00a | 69.50 ± 0.29e | 7.05 ± 0.03b | 3.75 ± 0.03ab | 15.40 ± 0.23c |
| G5 | 0.30 ± 0.00a | 71.03 ± 0.30d | 7.25 ± 0.03a | 3.85 ± 0.03a | 14.50 ± 0.29d |
| G6 | 0.31 ± 0.01a | 68.50 ± 0.29e | 7.19 ± 0.01a | 3.40 ± 0.06b | 14.50 ± 0.29d |
| G7 | 0.26 ± 0.00b | 75.10 ± 0.06d | 7.09 ± 0.06b | 3.60 ± 0.03b | 18.50 ± 0.29a |
| G8 | 0.21 ± 0.02b | 82.50 ± 0.29c | 6.82 ± 0.70d | 2.65 ± 0.03c | 13.00 ± 0.21ef |
| ANOVA Sig. | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mean values ± standard error. Means of treatments having the same letter(s) within a column are not significantly different (p < 0.05).
ANOVA = analysis of variance; BUN = blood urea nitrogen; CRE = creatinine; Glob = globulins; GLU, glucose; TP = total phosphorus.
Figure 6Histological changes in rat small intestine induced by E110, E122, and their in vitro or in vivo degradation products. C = cryptic region; D = desquamation of the surface epithelium; DI = degenerated intestinal crypts; EH = epithelial hyperplasia; Hp = hyperplasia in the mucosal epithelium; IC = inflammatory cells infiltrations; IL = intestinal lumen; LH = lymphoid hyperplasia; LP = lamina propria; ME = mucosal epithelium; ML = muscle layer; MM = muscularis mucosa; MU = mucosal layer; Oe = oedema; Pc = pericryptic region; SL = submucosal layer; Sm = submucosal; Su = surface epithelium; Vi = villi.